Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$572.38(as of Aug 25, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$572.38
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,182
CountyUSA
Market Cap$62,477.2M
EBIDTA4,466.8M
10-Day Moving Average575.78
P/E Ratio13.94
20-Day Moving Average566.58
Forward P/E Ratio16.18
50-Day Moving Average550.66
Earnings per Share39.67
200-Day Moving Average634.33
Profit Margin37.86%
RSI52.71
Shares Outstanding104.2M
ATR17.68
52-Week High1,206.03
Volume880,511
52-Week Low475.77
Book Value29,938.9M
P/B Ratio2.08
Upper Keltner606.36
P/S Ratio4.37
Lower Keltner526.81
Debt-to-Equity Ratio606.36
Next Earnings Date10/30/2025
Cash Surplus-1,671.2M
Next Ex-Dividend DateUnknown
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of Aug 26, 2025
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.